EX-10.15





 Exhibit 10.15 
 




 July 8, 2021 
 Shelley B.
Thunen 
 c/o RxSight, Inc. 
 100 Columbia, 

Aliso Viejo, CA 92656 
 Re: Confirmatory Employment Letter

 Dear Shelley: 
 This letter agreement (the
“Agreement”) is entered into between Shelley B. Thunen (“you”) and RxSight, Inc. (the “Company” or “we”). This Agreement is effective as of July 16, 2021 . The purpose of this
Agreement is to confirm the terms and conditions of your employment. 
 1.    Position. Your position will continue to be Chief
Financial Officer, and you will continue to report to Ron Kurtz, the Company’s President & Chief Executive Officer or to such other person as the Company subsequently may determine. This is a full-time position. You will perform the
duties and have the responsibilities and authority customarily performed and held by an employee in your position or as otherwise may be assigned or delegated to you by the Company. While you render services to the Company, you will not engage in
any other employment, consulting or other business activity (whether full time or part-time) that would create a conflict of interest with the Company. By signing this Agreement, you reconfirm to the Company that you have no contractual commitments
or other legal obligations that would prohibit you from performing your duties for the Company. 
 2.    Cash Compensation. Your
current annual base salary is $375,000, which will be payable, less applicable withholdings and deductions, in accordance with the Company’s normal payroll practices. Your annual base salary will be subject to review and adjustment based upon
the Company’s normal performance review practices. 
 3.    Annual Bonus. You are eligible to earn an annual cash bonus with
a target value of 50% of your base salary, based on achieving the Company’s achievement of corporate performance objectives established by the Company’s Board of Directors or an authorized committee thereof (the “Committee”) and
payable upon achievement of the corporate objectives as determined by the Committee. If any portion of such bonus is earned, it will be paid when practicable after the Committee determines it has been earned, subject to you remaining employed with
the Company through the payment date. Your annual bonus opportunity will be subject to review and adjustment based upon the Company’s normal performance review practices. 












 4.    Equity Awards. You will be eligible to receive awards of stock options,
restricted stock units or other equity awards pursuant to any plans or arrangements the Company may have in effect from time to time. The Committee will determine in its discretion whether you will be granted any such equity awards and the terms of
any such award in accordance with the terms of any applicable plan or arrangement that may be in effect from time to time. Upon the effectivity of the Company’s initial public offering (IPO) you will be granted stock options with a value of
$900,000, based upon a Black-Scholes model on the closing price of the Company’s common stock on the date of the IPO. 

5.    Employee Benefits. As a regular full-time employee of the Company, you will continue to be eligible to participate in
Company-sponsored benefits in accordance with the terms of the Company’s policies and benefits plan. Information regarding coverage, eligibility, and other information regarding these benefits is set forth in more detailed documents that are
available from the Company. With the exception of the Company’s at-will employment policy, discussed below, the Company may, from time to time, in its sole discretion, modify or eliminate its policies
and/or benefits offered to employees. 
 6.    Severance. You will be eligible to enter into a Change in Control and Severance
Agreement (the “Severance Agreement”) applicable to you based on your position with the Company. The Severance Agreement will specify the severance payments and benefits you would be eligible to receive in connection with certain
terminations of your employment with the Company. These protections will supersede all other severance payments and benefits you would otherwise currently be eligible for to, or would become eligible for in the future, under any plan, program or
policy that the Company may have in effect from time to time. 
 7.    Proprietary Information and Inventions Agreement. As an
employee of the Company, you will continue to have access to certain confidential information of the Company and you may, during the course of your employment, develop certain information or inventions that will be the property of the Company. To
protect the interests of the Company, your acceptance of this Agreement confirms that the terms of the Company’s Proprietary Information and Inventions Agreement you previously signed on (date) with the Company (the “PIIA”)
still apply. 
 8.    Employment Relationship. Employment with the Company will continue to be for no specific period of time.
Your employment with the Company will continue to be “at will,” meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause. Any contrary representations that may have been
made to you are superseded by this Agreement. This is the full and complete agreement between you and the Company on this term. Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and
procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and a duly authorized officer of the Company (other than you). 

  
 RxSight, Inc., 100
Columbia, Suite 120, Aliso Viejo, CA, 92656 
  
 2 













 9.    Protected Activity Not Prohibited. Nothing in this Agreement or in any
other agreement between you or the Company, as applicable, will in any way limit or prohibit you from engaging for a lawful purpose in any Protected Activity. For purposes of this Agreement, “Protected Activity” means filing a
charge or complaint, or otherwise communicating, cooperating, or participating with, any state, federal, or other governmental agency, including but not limited to the U.S. Securities and Exchange Commission, the Equal Employment Opportunity
Commission, and the National Labor Relations Board. Notwithstanding any restrictions set forth in this Agreement or in any other agreement between you or the Company, as applicable, you understand that you are not required to obtain authorization
from the Company prior to disclosing information to, or communicating with, such agencies, nor are you obligated to advise the Company as to any such disclosures or communications. In making any such disclosures or communications, you agree to take
all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute confidential information (within the meaning of the PIIA) to any parties other than the relevant government agencies. You further
understand that “Protected Activity” does not include the disclosure of any Company attorney-client privileged communications, and that any such disclosure without the Company’s written consent will constitute a material breach
of this Agreement. You acknowledge that the Company has provided you with notice in compliance with the Defend Trade Secrets Act of 2016 regarding immunity from liability for limited disclosures of trade secrets. The full text of the notice is
attached in Exhibit A. 
 10.    Miscellaneous. This Agreement, along with the PIIA and the Severance Agreement, constitute the
entire agreement between you and the Company regarding the subject matters discussed herein, and they supersede all prior negotiations, representations or agreements between you and the Company. For the avoidance of doubt, other than with respect to
Section 9 of this Agreement, nothing in this Agreement will supersede the terms and provisions of the PIIA. This Agreement may only be modified by a written agreement signed by you and the Company’s Board of Directors 

To confirm the current terms and conditions of your employment, please sign and date in the spaces indicated and return this Agreement to the Company. 

 

			
	Sincerely,
	
	RxSIGHT, Inc.
		
	By:	 	     /s/ J. Andy Corley

	
	 J. Andy Corley

	 Chairman of the Board of Directors



  
 RxSight, Inc., 100
Columbia, Suite 120, Aliso Viejo, CA, 92656 
  
 3 













 I have read and understood this Agreement and hereby acknowledge, accept and agree to the terms as set forth
herein and further acknowledge that no other commitments were made to me as part of my employment offer except as specifically set forth herein. 
  

	
	            /s/ Shelley
Thunen                                        
Shelley B. Thunen
	
	Date:     7/8/2021                    


  
 RxSight, Inc., 100
Columbia, Suite 120, Aliso Viejo, CA, 92656 
  
 4 













 Exhibit A 

SECTION 7 OF THE DEFEND TRADE SECRETS ACT OF 2016 

“ . . . An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret
that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or
(B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. . . . An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may
disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual—(A) files any document containing the trade secret under seal; and (B) does not disclose the trade
secret, except pursuant to court order.” 

  
 RxSight, Inc., 100
Columbia, Suite 120, Aliso Viejo, CA, 92656 
  
 5